
Wednesday, November 09, 2011 10:27:52 AM
Liked By
Spread the love. Be the first to like this post!
Recent ELAN News
- Elanco Launches Varenzin™-CA1 (molidustat oral suspension) – the First-of-its-Kind Oral Treatment for Anemia in Cats with Chronic Kidney Disease • Business Wire • 09/07/2023 08:15:00 PM
- Elanco to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference • Business Wire • 09/05/2023 09:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 08:11:14 PM
- Elanco Animal Health Reports Second Quarter 2023 Results and Raises Full Year Guidance • Business Wire • 08/07/2023 10:33:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 10:30:41 AM
- Elanco Releases 2022 Environmental, Social and Governance Report, Demonstrating Sustainability Progress in Internal Operations and Customer Collaborations • Business Wire • 07/20/2023 12:00:00 PM
- Elanco Confirms Date and Conference Call for Second Quarter 2023 Financial Results Announcement • Business Wire • 07/18/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 09:27:18 PM
- Environmental Protection Agency (EPA) Completes Review of Seresto® Collar and Confirms Continued Registration; Data Affirms Safety Profile of the Product • Business Wire • 07/13/2023 09:24:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 08:15:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/06/2023 08:47:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:17:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:17:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:07:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:05:17 PM
- Elanco to Participate in Goldman Sachs 44th Annual Global Healthcare Conference • Business Wire • 06/05/2023 12:00:00 PM
- Elanco to Participate in Stifel 2023 Jaws and Paws Conference • Business Wire • 05/25/2023 12:00:00 PM
- Elanco Animal Health Reports First Quarter 2023 Results • Business Wire • 05/09/2023 10:34:00 AM
- Elanco Receives USDA License for Canine Virus Treatment • Dow Jones News • 05/02/2023 01:21:00 PM
- Elanco Announces Breakthrough Treatment for Deadly Canine Parvovirus • Business Wire • 05/02/2023 12:30:00 PM
- California Dairies, Inc. and DSM Venturing Complete Strategic Investment in Athian • PR Newswire (US) • 05/01/2023 11:35:00 PM
- Elanco Animal Health's Varenzin-CA1 Gets Conditional FDA Approval to Treat Anemia in Cats • Dow Jones News • 05/01/2023 07:47:00 PM
- Elanco Confirms Date and Conference Call for First Quarter 2023 Financial Results Announcement • Business Wire • 04/18/2023 12:00:00 PM
- Tyson Ventures invests in Athian's cloud-based carbon credit marketplace for livestock sector • PR Newswire (US) • 03/14/2023 12:00:00 PM
- Elanco to Participate in the Barclays Global Healthcare Conference • Business Wire • 03/09/2023 01:00:00 PM
FEATURED Trio Petroleum Corp Provides Update on Testing of the HV-1 Discovery Well • Sep 21, 2023 9:38 AM
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation • GNPX • Sep 20, 2023 8:45 AM
Caduceus Provides Update on Its Plans for The Second Half of The Fiscal Year • CSOC • Sep 20, 2023 8:26 AM
RESILIENT ENERGY INC. (RENI) PURSUING ACQUISITION TARGETS • RENI • Sep 19, 2023 10:30 AM
Aether Global Innovations Corp. Signs Strategic Partnership MOU with STA, a cutting-edge, innovative and bespoke technology solutions provider • AETHF • Sep 19, 2023 9:11 AM
From Instagram to High Times: Unpacking the Power of Vast User Networks • META • Sep 19, 2023 8:45 AM